Jeffrey S. Hatfield - Net Worth and Insider Trading

Jeffrey S. Hatfield Net Worth

The estimated net worth of Jeffrey S. Hatfield is at least $5 Million dollars as of 2024-05-04. Jeffrey S. Hatfield is the CEO of Vitae Pharmaceuticals Inc and owns about 244,996 shares of Vitae Pharmaceuticals Inc (VTAE) stock worth over $5 Million. Details can be seen in Jeffrey S. Hatfield's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey S. Hatfield has not made any transactions after 2016-09-14 and currently still holds the listed stock(s).

Transaction Summary of Jeffrey S. Hatfield

To

Jeffrey S. Hatfield Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey S. Hatfield owns 6 companies in total, including Viridian Therapeutics Inc (VRDN) , aTyr Pharma Inc (LIFE) , and Larimar Therapeutics Inc (LRMR) among others .

Click here to see the complete history of Jeffrey S. Hatfield’s form 4 insider trades.

Insider Ownership Summary of Jeffrey S. Hatfield

Ticker Comapny Transaction Date Type of Owner
VRDN Viridian Therapeutics Inc 2021-02-04 director
LIFE aTyr Pharma Inc 2017-04-03 director
LRMR Larimar Therapeutics Inc 2017-10-09 director & Chief Executive Officer
2016-11-01 director
2016-10-24 director & Chief Executive Officer
2020-12-09 director

Jeffrey S. Hatfield Latest Holdings Summary

Jeffrey S. Hatfield currently owns a total of 1 stock. Jeffrey S. Hatfield owns 244,996 shares of Vitae Pharmaceuticals Inc (VTAE) as of September 14, 2016, with a value of $5 Million.

Latest Holdings of Jeffrey S. Hatfield

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VTAE Vitae Pharmaceuticals Inc 2016-09-14 244,996 21.00 5,144,916

Holding Weightings of Jeffrey S. Hatfield


Jeffrey S. Hatfield Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey S. Hatfield has made a total of 0 transactions in Vitae Pharmaceuticals Inc (VTAE) over the past 5 years. The most-recent trade in Vitae Pharmaceuticals Inc is the sale of 50,000 shares on September 14, 2016, which brought Jeffrey S. Hatfield around $1 Million.

Insider Trading History of Jeffrey S. Hatfield

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey S. Hatfield Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeffrey S. Hatfield Ownership Network

Ownership Network List of Jeffrey S. Hatfield

No Data

Ownership Network Relation of Jeffrey S. Hatfield


Jeffrey S. Hatfield Owned Company Details

What does Viridian Therapeutics Inc do?

Who are the key executives at Viridian Therapeutics Inc?

Jeffrey S. Hatfield is the director of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & other: See Remarks Fairmount Healthcare Fund Gp Llc , director & President and CEO Stephen F. Mahoney , and Chief Operating Officer Thomas W. Beetham .

Viridian Therapeutics Inc (VRDN) Insider Trades Summary

Over the past 18 months, Jeffrey S. Hatfield made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net sale of 89,514 shares made by Lara Meisner , a net sale of 100,000 shares made by Jonathan Violin , and a net sale of 89,000 shares made by Barrett Katz .

In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 278,514 shares of Viridian Therapeutics Inc (VRDN) were sold and 485,690 shares were bought by its insiders, resulting in a net purchase of 207,176 shares.

Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Viridian Therapeutics Inc Insider Transactions

No Available Data

Jeffrey S. Hatfield Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey S. Hatfield. You might contact Jeffrey S. Hatfield via mailing address: 11080 Roselle Street, San Diego Ca 92121.

Discussions on Jeffrey S. Hatfield

No discussions yet.